• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

子宫平滑肌瘤(UL)中不同类型驱动突变的罕见巧合。

A rare coincidence of different types of driver mutations among uterine leiomyomas (UL).

作者信息

Holzmann Carsten, Markowski Dominique Nadine, Bartnitzke Sabine, Koczan Dirk, Helmke Burkhard Maria, Bullerdiek Jörn

机构信息

Institute of Medical Genetics, University Rostock Medical Center, Ernst-Heydemann-Strasse 8, D-18057 Rostock, Germany.

Center of Human Genetics, University of Bremen, Leobener Strasse ZHG, D-28359 Bremen, Germany.

出版信息

Mol Cytogenet. 2015 Oct 14;8:76. doi: 10.1186/s13039-015-0177-9. eCollection 2015.

DOI:10.1186/s13039-015-0177-9
PMID:26468330
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4604635/
Abstract

Mutations of mediator subcomplex 12 (MED12) and of high mobility group protein AT-hook 2 (HMGA2) are driver mutations in uterine leiomyomas (UL) that have not been observed to coexist in one tumor and even rarely coexist in different UL tumors of one patient. Here we describe a patient who underwent hysterectomy because of multiple leiomyomas which were studied by cytogenetics, MED12 hotspot sequencing, and copy number variation arrays. Two of the UL tumors had different HMGA2 rearrangements not detected by G-banding. Two UL tumors had deletions of the long arm of chromosome 3, in one case associated with a MED12 mutation. Both deletions lead to the loss of MED12L showing strong similarity with MED12. It remains to be determined if this gene can play a role in leiomyomagenesis independent of MED12. In summary, the patient presented exhibits an unusual coincidence of different driver mutations among her leiomyomas.

摘要

中介体亚复合物12(MED12)和高迁移率族蛋白AT钩2(HMGA2)的突变是子宫平滑肌瘤(UL)中的驱动突变,尚未观察到它们在一个肿瘤中共存,甚至在一名患者的不同UL肿瘤中也很少共存。在此,我们描述了一名因多发性平滑肌瘤接受子宫切除术的患者,这些平滑肌瘤通过细胞遗传学、MED12热点测序和拷贝数变异阵列进行了研究。其中两个UL肿瘤具有不同的HMGA2重排,G显带未检测到。两个UL肿瘤存在3号染色体长臂缺失,其中一例与MED12突变相关。两种缺失均导致MED12L丢失,MED12L与MED12具有很强的相似性。该基因是否能独立于MED12在平滑肌瘤发生中发挥作用仍有待确定。总之,该患者的平滑肌瘤中出现了不同驱动突变的异常巧合。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/782a/4604635/a796b2bddc98/13039_2015_177_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/782a/4604635/911822872ff3/13039_2015_177_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/782a/4604635/bf5c4edd2e4c/13039_2015_177_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/782a/4604635/e00efd2383ed/13039_2015_177_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/782a/4604635/a796b2bddc98/13039_2015_177_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/782a/4604635/911822872ff3/13039_2015_177_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/782a/4604635/bf5c4edd2e4c/13039_2015_177_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/782a/4604635/e00efd2383ed/13039_2015_177_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/782a/4604635/a796b2bddc98/13039_2015_177_Fig4_HTML.jpg

相似文献

1
A rare coincidence of different types of driver mutations among uterine leiomyomas (UL).子宫平滑肌瘤(UL)中不同类型驱动突变的罕见巧合。
Mol Cytogenet. 2015 Oct 14;8:76. doi: 10.1186/s13039-015-0177-9. eCollection 2015.
2
MicroRNAs involved in the HMGA2 deregulation and its co-occurrence with MED12 mutation in uterine leiomyoma.miRNAs 参与 HMGA2 失调及其与子宫平滑肌瘤 MED12 突变的共同发生。
Mol Hum Reprod. 2018 Nov 1;24(11):556-563. doi: 10.1093/molehr/gay037.
3
Cytogenetically normal uterine leiomyomas without MED12-mutations - a source to identify unknown mechanisms of the development of uterine smooth muscle tumors.无MED12突变的细胞遗传学正常子宫平滑肌瘤——一种识别子宫平滑肌肿瘤未知发病机制的来源。
Mol Cytogenet. 2014 Nov 29;7(1):88. doi: 10.1186/s13039-014-0088-1. eCollection 2014.
4
Systematic molecular and clinical analysis of uterine leiomyomas from fertile-aged women undergoing myomectomy.对行子宫肌瘤剔除术的生育期妇女的子宫平滑肌瘤进行系统的分子和临床分析。
Hum Reprod. 2020 Oct 1;35(10):2237-2244. doi: 10.1093/humrep/deaa187.
5
mutations and fumarate hydratase inactivation in uterine adenomyomas.子宫腺肌瘤中的突变与富马酸水合酶失活
Hum Reprod Open. 2018 Nov 17;2018(4):hoy020. doi: 10.1093/hropen/hoy020. eCollection 2018.
6
Factors affecting the loss of MED12-mutated leiomyoma cells during in vitro growth.影响MED12突变型平滑肌瘤细胞在体外生长过程中损失的因素。
Oncotarget. 2017 May 23;8(21):34762-34772. doi: 10.18632/oncotarget.16711.
7
Characterization of MED12, HMGA2, and FH alterations reveals molecular variability in uterine smooth muscle tumors.MED12、HMGA2和FH改变的特征揭示了子宫平滑肌肿瘤中的分子变异性。
Mol Cancer. 2017 Jun 7;16(1):101. doi: 10.1186/s12943-017-0672-1.
8
Prevalence and clinical significance of mediator complex subunit 12 mutations in 362 Han Chinese samples with uterine leiomyoma.362例汉族子宫平滑肌瘤样本中介体复合物亚基12突变的患病率及临床意义
Oncol Lett. 2017 Jul;14(1):47-54. doi: 10.3892/ol.2017.6120. Epub 2017 May 4.
9
Highly heterogeneous genomic landscape of uterine leiomyomas by whole exome sequencing and genome-wide arrays.通过全外显子组测序和全基因组芯片分析子宫平滑肌瘤高度异质性的基因组格局
Fertil Steril. 2017 Feb;107(2):457-466.e9. doi: 10.1016/j.fertnstert.2016.10.035. Epub 2016 Nov 23.
10
Integrated data analysis reveals uterine leiomyoma subtypes with distinct driver pathways and biomarkers.综合数据分析揭示了具有不同驱动途径和生物标志物的子宫平滑肌瘤亚型。
Proc Natl Acad Sci U S A. 2016 Feb 2;113(5):1315-20. doi: 10.1073/pnas.1518752113. Epub 2016 Jan 19.

引用本文的文献

1
Prevalence and clinical significance of co-existing mutations in and in uterine fibroids of Australian women.澳大利亚女性子宫肌瘤中[具体基因名称1]和[具体基因名称2]共存突变的患病率及临床意义。
Front Reprod Health. 2023 Apr 11;5:1081092. doi: 10.3389/frph.2023.1081092. eCollection 2023.
2
Development of Primary Monolayer Cell Model and Organotypic Model of Uterine Leiomyoma.子宫平滑肌瘤原代单层细胞模型和器官型模型的建立。
Methods Protoc. 2022 Feb 6;5(1):16. doi: 10.3390/mps5010016.
3
Cytogenomic Profile of Uterine Leiomyoma: In Vivo vs. In Vitro Comparison.

本文引用的文献

1
Cytogenetically normal uterine leiomyomas without MED12-mutations - a source to identify unknown mechanisms of the development of uterine smooth muscle tumors.无MED12突变的细胞遗传学正常子宫平滑肌瘤——一种识别子宫平滑肌肿瘤未知发病机制的来源。
Mol Cytogenet. 2014 Nov 29;7(1):88. doi: 10.1186/s13039-014-0088-1. eCollection 2014.
2
Uterine fibroids: do we deal with more than one disease?子宫肌瘤:我们面对的是不止一种疾病吗?
Int J Gynecol Pathol. 2014 Nov;33(6):568-72. doi: 10.1097/PGP.0000000000000096.
3
Cell cultures in uterine leiomyomas: rapid disappearance of cells carrying MED12 mutations.
子宫平滑肌瘤的细胞基因组图谱:体内与体外比较
Biomedicines. 2021 Nov 26;9(12):1777. doi: 10.3390/biomedicines9121777.
4
Molecular and Cellular Insights into the Development of Uterine Fibroids.子宫纤维瘤发病机制的分子和细胞研究进展
Int J Mol Sci. 2021 Aug 6;22(16):8483. doi: 10.3390/ijms22168483.
5
Reasons to Reconsider Risk Associated With Power Morcellation of Uterine Fibroids.重新考虑与子宫肌瘤电切术相关风险的理由。
In Vivo. 2020 Jan-Feb;34(1):1-9. doi: 10.21873/invivo.11739.
6
Understanding Obesity as a Risk Factor for Uterine Tumors Using Drosophila.利用果蝇理解肥胖作为子宫肿瘤的风险因素。
Adv Exp Med Biol. 2019;1167:129-155. doi: 10.1007/978-3-030-23629-8_8.
7
Clinical, pathologic, cytogenetic, and molecular profiling in self-identified black women with uterine leiomyomata.对自我认定的患有子宫平滑肌瘤的黑人女性进行临床、病理、细胞遗传学和分子分析。
Cancer Genet. 2018 Apr;222-223:1-8. doi: 10.1016/j.cancergen.2018.01.001. Epub 2018 Feb 19.
8
Genetic heterogeneity in leiomyomas of deep soft tissue.深部软组织平滑肌瘤的基因异质性。
Oncotarget. 2017 Jul 25;8(30):48769-48781. doi: 10.18632/oncotarget.17953.
9
Factors affecting the loss of MED12-mutated leiomyoma cells during in vitro growth.影响MED12突变型平滑肌瘤细胞在体外生长过程中损失的因素。
Oncotarget. 2017 May 23;8(21):34762-34772. doi: 10.18632/oncotarget.16711.
子宫平滑肌瘤中的细胞培养:携带MED12突变的细胞迅速消失。
Genes Chromosomes Cancer. 2014 Apr;53(4):317-23. doi: 10.1002/gcc.22142. Epub 2014 Jan 21.
4
MED12 and HMGA2 mutations: two independent genetic events in uterine leiomyoma and leiomyosarcoma.MED12和HMGA2突变:子宫平滑肌瘤和平滑肌肉瘤中的两个独立遗传事件。
Mod Pathol. 2014 Aug;27(8):1144-53. doi: 10.1038/modpathol.2013.243. Epub 2014 Jan 3.
5
MED12 exon 2 mutations in uterine and extrauterine smooth muscle tumors.MED12 外显子 2 突变在子宫和子宫外平滑肌肿瘤中的作用。
Hum Pathol. 2014 Jan;45(1):65-70. doi: 10.1016/j.humpath.2013.08.005. Epub 2013 Nov 4.
6
Characterization of uterine leiomyomas by whole-genome sequencing.全基因组测序对子宫肌瘤的特征分析。
N Engl J Med. 2013 Jul 4;369(1):43-53. doi: 10.1056/NEJMoa1302736. Epub 2013 Jun 5.
7
Mediator complex subunit 12 exon 2 mutation analysis in different subtypes of smooth muscle tumors confirms genetic heterogeneity.中介复合物亚基 12 外显子 2 突变分析在不同类型的平滑肌肿瘤中证实了遗传异质性。
Hum Pathol. 2013 Aug;44(8):1597-604. doi: 10.1016/j.humpath.2013.01.006. Epub 2013 Mar 19.
8
Prevalence of MED12 mutations in uterine and extrauterine smooth muscle tumours.MED12 突变在子宫和子宫外平滑肌肿瘤中的流行率。
Histopathology. 2013 Mar;62(4):657-61. doi: 10.1111/his.12039. Epub 2013 Jan 24.
9
MED12 mutations occurring in benign and malignant mammalian smooth muscle tumors.在良性和恶性哺乳动物平滑肌肿瘤中发生的 MED12 突变。
Genes Chromosomes Cancer. 2013 Mar;52(3):297-304. doi: 10.1002/gcc.22029. Epub 2012 Dec 8.
10
MED12 mutations in leiomyosarcoma and extrauterine leiomyoma.MED12 突变与平滑肌肉瘤和子宫外平滑肌瘤。
Mod Pathol. 2013 May;26(5):743-9. doi: 10.1038/modpathol.2012.203. Epub 2012 Dec 7.